跳至主要内容
临床试验/CTRI/2025/03/082732
CTRI/2025/03/082732尚未招募2 期

A randomised controlled clinical trial to evaluate the efficacy of Rasanjanadi Lepa in mangament Of Nadi Vrana (Pilonidal Sinus)

Dr Sarvagya Pathak1 个研究点 分布在 1 个国家目标入组 172 人开始时间: 2025年3月24日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
172
试验地点
1
主要终点
Wound dimension

研究概览

简要总结

This study is Randomised ,Parallel group, active controlled trial to evaluate the safety and efficacy of Rasanjanadi lepa, in 172 patient aged between 16 to 45 years , over a period of 18 months. The patient will be of 21 days . During the trial assessment will be done on 0th , 7th, 14th, 21th, 28th days . After trial , follow up will be done after 43rd , 58th, 73rd, & 88th day after cessation of procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Age group of patient 16 to 45 years.
  • Patient diagnosed with Pilonidal Sinus & Abscess as per diagnostic criteria .
  • Patient capable of reading , completing, and assigning the consent from participating in the study.

排除标准

  • Presenting with dry & hard ulcer Presenting with Vatadhik Lakshan pregnant and lactating women Addiction to drugs and alcohol Abnormal bleeding from the wound using drugs that affect wound healing such as corticosteroids Using antibiotics prior to surgical intervention Not continuing the proposed treatment until the end of the study or request to leave the study History of severe allergy or anaphylactic shock caused by similar treatment Patient who has undergone organ transpiration Known case of connective tissue disease Known allergies to herbal drugs.

结局指标

主要结局

Wound dimension

时间窗: 21 days

Depth of wound

时间窗: 21 days

Wound excaudate quantity

时间窗: 21 days

Improvement in other symptoms or Pilonidal Sinus

时间窗: 21 days

Bacterial load by culture & sensitivity test

时间窗: 21 days

CRP

时间窗: 21 days

Time period

时间窗: 21 days

Wound volumetry

时间窗: 21 days

次要结局

  • Improvement in other symptoms like pain(After analysing all the parameters the result will be assessed on the basis of symptomatic relief and improvement.)

研究者

发起方
Dr Sarvagya Pathak
申办方类型
Other [Dr.Sarvagya Pathak]
责任方
Principal Investigator
主要研究者

Dr Sarvagya Pathak

Kunwar Shekhar Vijendra Ayurved Medical College and Research Centre , Gangoh-247341.

研究点 (1)

Loading locations...

相似试验